These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Conservative treatment of diabetic microangiopathy and macroangiopathy]. Smahelová A Cas Lek Cesk; 2009; 148(2):72-5, 77. PubMed ID: 19637441 [TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis and therapy of diabetic angiopathies]. Dieterle P Med Klin; 1969 Jan; 64(2):55-9. PubMed ID: 5767150 [No Abstract] [Full Text] [Related]
12. [Kidney microangiopathy in diabetes (its nature, pathogenesis and treatment)]. Zlateva S; Belovezhdov N; Khristov V Vutr Boles; 1979; 18(3):154-60. PubMed ID: 383116 [No Abstract] [Full Text] [Related]
13. [Etiopathogenesis of diabetic microangiopathy]. Schulz B; Zander E Z Arztl Fortbild (Jena); 1990; 84(21):1111-5. PubMed ID: 2281699 [No Abstract] [Full Text] [Related]
14. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502 [TBL] [Abstract][Full Text] [Related]